PharmGen Science, Inc. (KRX: 004720)

PharmGen Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	86,965	111,355	105,470	159,511	165,783	74,173
Market Cap Growth	2.79%	5.58%	-33.88%	-3.78%	123.51%	-13.05%
Enterprise Value	89,815	127,335	126,753	178,736	154,760	77,274
Last Close Price	4795.00	6200.00	6680.00	10500.00	11300.00	6370.00
PE Ratio	150.61	20.24	1.98	5.79	18.13	245.00
PS Ratio	0.48	0.67	0.70	1.45	1.72	0.78
PB Ratio	0.36	0.49	0.51	1.26	1.98	1.32
P/TBV Ratio	0.40	0.49	0.51	1.26	1.99	1.34
P/FCF Ratio	47.23	35.09	-	-	-	-
P/OCF Ratio	33.81	20.47	-	20.49	61.96	29.39
EV/Sales Ratio	0.52	0.76	0.84	1.63	1.60	0.81
EV/EBITDA Ratio	8.92	9.52	11.76	-	146.36	21.96
EV/EBIT Ratio	16.41	13.95	17.10	-	-	64.54
EV/FCF Ratio	48.78	40.13	-	-	-	-
Debt / Equity Ratio	0.16	0.17	0.19	0.38	0.26	0.35
Debt / EBITDA Ratio	2.51	2.84	3.66	-	20.24	5.62
Debt / FCF Ratio	20.55	11.96	-	-	-	-
Asset Turnover	0.50	0.51	0.56	0.62	0.82	0.96
Inventory Turnover	2.74	3.32	3.87	3.11	2.85	3.48
Quick Ratio	1.18	1.16	0.70	0.76	1.38	1.16
Current Ratio	1.61	1.51	1.03	1.09	1.99	1.67
Return on Equity (ROE)	0.24%	2.63%	41.95%	30.80%	13.05%	0.42%
Return on Assets (ROA)	1.89%	1.75%	1.72%	-1.73%	-1.01%	0.76%
Return on Capital (ROIC)	2.39%	2.22%	2.20%	-2.21%	-1.32%	0.98%
Earnings Yield	0.66%	5.14%	66.43%	20.35%	5.56%	0.41%
FCF Yield	2.12%	2.85%	-10.63%	-14.40%	-1.00%	-4.90%
Buyback Yield / Dilution	23.67%	3.68%	-16.09%	-23.81%	-30.15%	3.86%
Total Shareholder Return	23.67%	3.68%	-16.09%	-23.81%	-30.15%	3.86%

Source: S&P Capital IQ. Standard template. Financial Sources.